Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.75 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.75 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.54 |
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.51 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.49 |
| ▸ | TUBB | P07437 | 1/20 | 0.49 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.49 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.49 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.49 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.49 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.49 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.49 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.49 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.49 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.49 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.49 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.49 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.49 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycycoumarin SCHEMBL29390258 | 1.00 | PTPN1 (0.75) | PTPN1DYRK1APDE4DAKT1ACHE | |
| Glycyrin SCHEMBL5327472 | 0.94 | PTPN1 (0.75) | PTPN1DYRK1APDE4DAKT1ACHE | |
| Glycyrin SCHEMBL29388094 | 0.94 | PTPN1 (0.75) | PTPN1DYRK1APDE4DAKT1ACHE | |
| Licocoumarone SCHEMBL30220504 | 0.86 | PTPN1 (1.00) | PTPN1DYRK1APDE4DAKT1TUBB4A | |
| Licocoumarone SCHEMBL758659 | 0.86 | PTPN1 (1.00) | PTPN1DYRK1APDE4DAKT1TUBB4A | |
| Licoricidin SCHEMBL4468990 | 0.81 | PTPN1 (0.70) | PTPN1DYRK1APDE4DAKT1ACHE | |
| SCHEMBL29391195 | 0.79 | PTPN1 (1.00) | PTPN1DYRK1APDE4DAKT1ACHE | |
| SCHEMBL22704765 | 0.79 | PTPN1 (1.00) | PTPN1DYRK1APDE4DAKT1ACHE | |
| Glycyrol SCHEMBL758197 | 0.78 | ALOX5AP (0.65) | PTPN1DYRK1APDE4DAKT1TUBB4A | |
| Glycyrol SCHEMBL29499208 | 0.78 | ALOX5AP (0.65) | PTPN1DYRK1APDE4DAKT1TUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177467-A1 | COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS | UNIV YALE (US) | 2025-06-05 | — | — | US | claimed |
| EP-4486363-A1 | COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS | Yale University (US) | 2025-01-08 | — | — | EP | claimed |
| WO-2024033113-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2024-02-15 | — | — | WO | claimed |
| EP-4321148-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - Skin & Hair Innovations GmbH (DE) | 2024-02-14 | — | — | EP | claimed |
| WO-2023167869-A1 | COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS | YALE UNIVERSITY (US) | 2023-09-07 | — | — | WO | claimed |
| US-20230276831-A1 | Food/Beverage Article | KIKKOMAN CORPORATION (JP) | 2023-09-07 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4176731-A1 | FOOD/BEVERAGE ARTICLE | Kikkoman Corporation (JP) | 2023-05-10 | — | — | EP | claimed |
| CN-115901978-A | Detection method of traditional Chinese medicine composition | 山东新时代药业有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-111443154-B | Research method of medicinal genetic relationship of glycyrrhiza | 贵州中医药大学 | 2023-03-07 | — | — | CN | claimed |
| CN-105497018-A | Novel application of glycycoumarin as PBK/TOPK (PDZbinding-kinase/T-LAK celloriginated protein kinase) protein inhibitor | UNIV CHINA AGRICULTURAL | 2016-04-20 | — | — | CN | claimed |
| CN-103565800-B | Novel application of glycycoumarin in prevention and treatment of alcoholic liver injury | UNIV CHINA AGRICULTURAL | 2015-06-17 | — | — | CN | claimed |
| CN-103565800-A | Novel application of glycycoumarin in prevention and treatment of alcoholic liver injury | UNIV CHINA AGRICULTURAL | 2014-02-12 | — | — | CN | claimed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | claimed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | claimed |
| CN-1633302-A | Method for producing high-quality hydrophobic licorice extract | KANEGAFUCHI CHEMICAL IND (JP) | 2005-06-29 | — | — | CN | claimed |
| US-20050118288-A1 | Method for producing high-quality hydropbic licorice extract | KANEKA CORPORATION (JP) | 2005-06-02 | — | — | US | claimed |
| US-20050014819-A1 | Peroxisome proliferator activated receptor ligands and process for producing the same | KANEKA CORPORATION (JP) | 2005-01-20 | — | — | US | claimed |
| EP-1477177-A1 | PROCESS FOR PRODUCING HYDROPHOBIC GLYCYRRHIZA EXTRACT WITH HIGH QUALITIES | KANEKA CORPORATION (JP) | 2004-11-17 | — | — | EP | claimed |
| EP-1440688-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2004-07-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | PPARG, PPARA, PPARD | PTPN1 945/4885DYRK1A 3340/4885PDE4D 4132/4885 |
| US-20050014819-A1 | Peroxisome proliferator activated receptor ligands and process for producing the same | PPARG, PPARA, PPARD | PTPN1 933/4885DYRK1A 3269/4885PDE4D 3902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.